Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05054790 · ClinicalTrials.gov registry record · Phase 2
Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Not yet
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT05054790 is a Phase 2 study that has not yet begun recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants.
The verdict
NCT05054790, a Phase 2 study, has not yet begun recruiting, sponsored by Wake Forest University Health Sciences.
- NOT YET RECRUITING
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to find out if autologous "neo-bladder" construct for the treatment of fibrotic and/or contracted bladder can improve bladder compliance and be safe long term. The neo-bladder is like a reservoir or pouch that will be surgically attached to the bladder to assist with urine collection.
Interventions
- BIOLOGICAL "Neo-Bladder" Construct
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-12 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05054790
The ClinicalTrials.gov registry entry for NCT05054790 describes a study currently listed as not yet recruiting, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which "Neo-Bladder" Construct is the first listed.
NCT05054790 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05054790 about?
NCT05054790 is a clinical study titled "Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct". The purpose of this research study is to find out if autologous "neo-bladder" construct for the treatment of fibrotic and/or contracted bladder can improve bladder compliance and be safe long term. The neo-bladder is like a reservoir or pouch that will be surgically attached to the bladder to assist...
What is the current status of trial NCT05054790?
This trial is currently not yet recruiting. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2026-12. Estimated completion is 2027-12.
What interventions are being tested in trial NCT05054790?
The interventions under investigation include: "Neo-Bladder" Construct (BIOLOGICAL).
Who is sponsoring clinical trial NCT05054790?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.